One study reported that metformin decreased the activity of DNMTs on the methyltransferase-like 3 (METTL3) promoter (an enzyme that causes m6A modifications in RNA), decreasing its methylation and favoring its expression and activity to promote let-7b expression in lung cancer cells [85]. Here, METTL3 is linked to lung carcinoma.